Q2 2024 Holdings
Filed 2024-08-14 | 46 holdings | $517.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $98.7M | 691,743 | 19.1% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $83.8M | 92,593 | 16.2% |
| ELI Lilly & CoPut | COM | 532457958 | $67.9M | 75,000 | 13.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $54.8M | 442,504 | 10.6% |
| Novo-Nordisk A SPut | ADR | 670100955 | $44.2M | 310,000 | 8.6% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $24.0M | 452,979 | 4.6% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $14.9M | 190,752 | 2.9% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $14.8M | 216,519 | 2.9% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $8.9M | 18,900 | 1.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $8.5M | 35,000 | 1.6% |
| Viking Therapeutics IncCall | COM | 92686J906 | $8.0M | 150,000 | 1.5% |
| Insmed IncPut | COM PAR $.01 | 457669957 | $7.4M | 110,000 | 1.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $7.1M | 87,848 | 1.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $6.5M | 15,138 | 1.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $6.2M | 45,000 | 1.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $5.8M | 76,255 | 1.1% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $4.3M | 124,440 | 0.8% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $4.2M | 119,488 | 0.8% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $3.9M | 94,424 | 0.7% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $3.8M | 85,765 | 0.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $3.6M | 53,436 | 0.7% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $3.4M | 500,000 | 0.7% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $3.0M | 62,479 | 0.6% |
| Merus N V | COM | N5749R100 | $3.0M | 50,171 | 0.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $2.8M | 75,300 | 0.5% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $2.3M | 58,400 | 0.4% |
| Springworks Therapeutics Inc | COM | 85205L107 | $2.0M | 53,930 | 0.4% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $1.9M | 54,392 | 0.4% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $1.9M | 130,790 | 0.4% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.6M | 40,000 | 0.3% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $1.5M | 421,359 | 0.3% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $1.4M | 6,905 | 0.3% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.2M | 57,178 | 0.2% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $1.0M | 54,285 | 0.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $1.0M | 7,440 | 0.2% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $997.0K | 52,476 | 0.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $990.8K | 48,263 | 0.2% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $914.0K | 20,000 | 0.2% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $905.0K | 20,000 | 0.2% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $883.1K | 101,500 | 0.2% |
| Annexon Inc(ANNX) | COM | 03589W102 | $722.7K | 147,485 | 0.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $656.1K | 90,490 | 0.1% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $605.7K | 13,440 | 0.1% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $537.5K | 50,000 | 0.1% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $436.2K | 1,557 | 0.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $410.8K | 2,600 | 0.1% |